|
|
|
|
LEADER |
01668nam a22002775i 4500 |
001 |
000280994 |
005 |
20220118101157.0 |
007 |
cr nn 008mamaa |
008 |
100301s2005 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387264769
|
024 |
7 |
|
|a 10.1007/b137670
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Fibrogenesis :
|b Cellular and Molecular Basis /
|c edited by Moshe S. Razzaque.
|
250 |
|
|
|a 1st ed. 2005.
|
260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2005.
|
300 |
|
|
|a XVI, 216 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Medical Intelligence Unit
|
505 |
0 |
|
|a Tissue Scarring -- Pathological Significance of Renal Expression of Proinflammatory Molecules -- Oxidative Stress, Lipoproteins and Angiotensin II -- Involvement of NF-?B in Renal Inflammation and Sclerosis -- Low-Denisty Lipoprotein and Glomerulosclerosis -- Molecular Developments in the Treatment of Renal Fibrosis -- Myocardial Infarction and Cardiac Fibrogenesis -- Cardiac Fibrosis and Aging -- Matrix Remodeling and Atherosclerosis Effect of Age -- Molecular and Cellular Aspects of Liver Fibrosis -- Recent Therapeutic Developments in Hepatic Fibrosis -- Reversibility of Liver Fibrosis -- Can Manipulation of Apoptotic Cell Death Benefit Tissue Scarring? -- Pulmonary Fibrogenesis -- Silica-Induced Inflammatory Mediators and Pulmonary Fibrosis.
|
650 |
|
0 |
|a Molecular biology.
|
650 |
1 |
4 |
|a Molecular Medicine.
|
700 |
1 |
|
|a Razzaque, Moshe S.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|